NEXTHERA CAPITAL LP
data from 30/06/2019
Capitalization
$ 120.064 M
45.71 %
Performance
$ -162.635 M
-11.69 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2019/06/30 | ICPT | Intercept Pharmaceuticals Inc | 10.10% | 12.130 M $ | 152441 | 2019/03/31 | -386.408 K $ | -28.90 % |
| 2019/06/30 | INSM | Insmed Inc | 10.04% | 12.051 M $ | 470741 | 2016/03/31 | -940.910 K $ | -11.39 % |
| 2019/06/30 | BOLD | Audentes Therapeutics Inc | 9.27% | 11.131 M $ | 294013 | 2018/06/30 | 155.384 K $ | 1.59 % |
| 2019/06/30 | NBIX | Neurocrine Biosciences Inc | 6.50% | 7.800 M $ | 92380 | 2019/03/31 | -83.899 K $ | -3.96 % |
| 2019/06/30 | SRPT | Sarepta Therapeutics Inc | 6.37% | 7.646 M $ | 50317 | 2019/03/31 | 818.469 K $ | 32.29 % |
| 2019/06/30 | GBT | Global Blood Therapeutics Inc | 6.23% | 7.485 M $ | 142305 | 2016/12/31 | 89.711 K $ | 1.95 % |
| 2019/06/30 | IMMU | Immunomedics Inc | 6.06% | 7.270 M $ | 524140 | 2017/09/30 | -1.185 M $ | -18.43 % |
| 2019/06/30 | CHRS | Coherus Biosciences Inc | 5.82% | 6.991 M $ | 316316 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | ASND | Ascendis Pharma A/S | 5.78% | 6.940 M $ | 60266 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | PCRX | Pacira BioSciences Inc | 5.40% | 6.484 M $ | 149086 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | URGN | UroGen Pharma Ltd | 5.29% | 6.357 M $ | 176866 | 2019/03/31 | -50.383 K $ | -1.03 % |
| 2019/06/30 | QURE | uniQure NV | 3.90% | 4.680 M $ | 59883 | 2019/03/31 | 652.227 K $ | 28.19 % |
| 2019/06/30 | AMRN | Amarin Corp PLC | 3.72% | 4.465 M $ | 230295 | 2019/03/31 | -130.851 K $ | -4.24 % |
| 2019/06/30 | ABBV | AbbVie Inc | 3.19% | 3.831 M $ | 52681 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | BHVN | Biohaven Pharmaceutical Holdin | 3.14% | 3.773 M $ | 86165 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | MYL | Mylan NV | 1.63% | 1.953 M $ | 102560 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | ITCI | Intra-Cellular Therapies Inc | 1.55% | 1.865 M $ | 143665 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | REGN | Regeneron Pharmaceuticals Inc | 1.48% | 1.774 M $ | 5668 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | MDGL | Madrigal Pharmaceuticals Inc | 1.35% | 1.616 M $ | 15423 | 2017/09/30 | -82.951 K $ | -19.20 % |
| 2019/06/30 | Dermira Inc | 1.10% | 1.320 M $ | 138102 | 2019/06/30 | 0.000 $ | 0.00 % | |
| 2019/06/30 | GILD | Gilead Sciences Inc | 1.05% | 1.263 M $ | 18697 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | ANAB | AnaptysBio Inc | 0.57% | 679.000 K $ | 12026 | 2019/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | AGN | Allergan PLC | 0.47% | 560.000 K $ | 3347 | 2017/12/31 | 272.219 K $ | 13.57 % |
| 2019/06/30 | HRTX | Heron Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2018/03/31 | 0.000 $ | 0.00 % |
| 2019/06/30 | EXEL | Exelixis Inc | 0.00% | 0.000 $ | 0 | 2018/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | DCPH | Deciphera Pharmaceuticals Inc | 0.00% | 0.000 $ | 0 | 2018/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | ACOR | Acorda Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2018/06/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | KNSA | Kiniksa Pharmaceuticals Ltd | 0.00% | 0.000 $ | 0 | 2019/03/31 | 0.000 $ | 0.00 % |
| 2019/06/30 | STML | Stemline Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2018/03/31 | 0.000 $ | 0.00 % |
| 2019/06/30 | BMRN | BioMarin Pharmaceutical Inc | 0.00% | 0.000 $ | 0 | 2019/03/31 | 0.000 $ | 0.00 % |
| 2019/06/30 | CBAY | Cymabay Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2017/09/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | CHMA | Chiasma Inc | 0.00% | 0.000 $ | 0 | 2018/09/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | NVS | Novartis AG | 0.00% | 0.000 $ | 0 | 2018/12/31 | 0.000 $ | 0.00 % |
| 2019/06/30 | BHC | Bausch Health Cos Inc | 0.00% | 0.000 $ | 0 | 2018/09/30 | 0.000 $ | 0.00 % |
| 2019/06/30 | SAGE | Sage Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2019/03/31 | 0.000 $ | 0.00 % |